M42 CEO Hasan Jasem Al Nowais Calls for a Global Shift Toward Preventative Healthcare
At the 7th Annual Longevity Forum in London, Hasan Jasem Al Nowais, Managing Director and Group CEO of M42, delivered …
All Posts
Lantern Pharma Expands Phase 2 Harmonic Clinical Trial to Japan and Taiwan
Lantern Pharma (NASDAQ: LTRN) has dosed the first patient in Japan as part of the expansion of its Phase 2 …
Cradle Raises $73M for Gen-AI Protein Engineering
Cradle has secured $73 million in a Series B funding round led by IVP, bringing its total funding to over …
LongeVC Announces Investment in Glyphic Biotechnologies, Developing Single-Molecule Protein Sequencing
LongeVC has announced its investment in Glyphic Biotechnologies, a company developing single-molecule protein sequencing technology.
Trogenix Emerges from Stealth with Precision Gene Therapy Platform to Target Aggressive Cancers
Trogenix Ltd has launched its Odysseus platform, leveraging Synthetic Super-Enhancer (SSE) technology to advance precision viral immunotherapy for aggressive cancers.
Novartis Expands Radiopharmaceutical Portfolio with $745M Deal with Ratio Therapeutics
Novartis has struck a licensing agreement with Boston-based biotech Ratio Therapeutics, securing global rights to a promising cancer candidate targeting …
Medable Adds Generative AI to Simplify and Speed Up Clinical Trials
Medable Inc. has introduced generative AI capabilities to its Medable Studio platform to streamline and accelerate digital and decentralized clinical …
40,000 NHS Healthcare Workers to Get AI Tool That Cuts Admin Time by 80%
A new partnership between Corti and BigHand will bring a specialized AI tool to 40,000 healthcare workers across 76 NHS …
Survey Highlights Critical Need for AI Adoption in Regulatory Affairs Amid Unsustainable Workloads
New research commissioned by ArisGlobal, a provider of life sciences technology solutions, reveals that surging regulatory workloads are forcing life …
What will be the key trends in AI innovation in the Pharmaceutical Industry in 2025?
The pharmaceutical industry is undergoing transformation thanks to artificial intelligence (AI) in particular GenAI. From drug discovery and manufacturing to …
Immunai and Teva Collaborate to Advance Clinical Trials in Oncology and Immunology
Immunai, an AI-driven biotech company focused on mapping the human immune system, has partnered with Teva Pharmaceuticals in a multi-year …
Enveda Advances AI-Discovered, Nature-Derived Drug ENV-294 to Phase 1 Trials
Enveda, a biotechnology company transforming nature’s chemistry into medicines using AI, has announced the FDA clearance of an investigational new …